Gill PS, Grewal N. Mirabegron: first β3 agonist in treatment of overactive bladder. Int J Basic Clin Pharmacol [Internet]. 2017 Feb. 4 [cited 2026 Apr. 16];1(2):120-1. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1410